BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 30634660)

  • 1. Performance of urinary C-C motif chemokine ligand 14 for the prediction of persistent acute kidney injury: a systematic review and meta-analysis.
    Chen YT; Pan HC; Hsu CK; Sun CY; Chen CY; Chen YH; Hsu HJ; Wu IW; Wu VC; Hoste E
    Crit Care; 2023 Aug; 27(1):318. PubMed ID: 37596698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic nutritional index as a predictive marker for acute kidney injury in adult critical illness population: a systematic review and diagnostic test accuracy meta-analysis.
    Chen JJ; Lee TH; Lai PC; Chang CH; Wu CH; Huang YT
    J Intensive Care; 2024 Apr; 12(1):16. PubMed ID: 38671543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proenkephalin as a biomarker correlates with acute kidney injury: a systematic review with meta-analysis and trial sequential analysis.
    Lin LC; Chuan MH; Liu JH; Liao HW; Ng LL; Magnusson M; Jujic A; Pan HC; Wu VC; Forni LG
    Crit Care; 2023 Dec; 27(1):481. PubMed ID: 38057904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of urinary Dickkopf-3 in the prediction of acute kidney injury: a systematic review meta-analysis.
    Xing H; Jiang Z; Wu Y; Ou S; Qin J; Xue L; Wu W
    Int Urol Nephrol; 2023 Dec; 55(12):3175-3188. PubMed ID: 37072601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and meta-analysis.
    Haase M; Bellomo R; Devarajan P; Schlattmann P; Haase-Fielitz A;
    Am J Kidney Dis; 2009 Dec; 54(6):1012-24. PubMed ID: 19850388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of Fractional Excretion of Urea in Acute Kidney Injury with Comparison to Fractional Excretion of Sodium: A Systematic Review and Meta-Analysis.
    Abdelhafez MO; Alhroob AA; Hawilla MOA; Rjoob AA; Abualia NM; Gorman EF; Hamadah AM; Gharaibeh KA
    Am J Med Sci; 2024 May; ():. PubMed ID: 38768779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calprotectin, an Emerging Biomarker of Interest in COVID-19: A Systematic Review and Meta-Analysis.
    Udeh R; Advani S; de Guadiana Romualdo LG; Dolja-Gore X
    J Clin Med; 2021 Feb; 10(4):. PubMed ID: 33672040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal measuring timing of cystatin C for early detection of contrast-induced acute kidney injury: A systematic review and meta-analysis.
    Chen CT; Chang LY; Chuang CW; Wang SC; Kao MC; Tzeng IS; Kuo KL; Wu CC; Tsai PS; Huang CJ
    Toxicol Lett; 2020 Jan; 318():65-73. PubMed ID: 31654803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma NGAL levels in stable kidney transplant recipients and the risk of allograft loss.
    Swolinsky JS; Hinz RM; Markus CE; Singer E; Bachmann F; Halleck F; Kron S; Naik MG; Schmidt D; Obermeier M; Gebert P; Rauch G; Kropf S; Haase M; Budde K; Eckardt KU; Westhoff TH; Schmidt-Ott KM
    Nephrol Dial Transplant; 2024 Feb; 39(3):483-495. PubMed ID: 37858309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic targeting of chronic kidney disease-associated DAMPs differentially contributing to vascular pathology.
    Mazzarino M; Cetin E; Bartosova M; Marinovic I; Ipseiz N; Hughes TR; Schmitt CP; Ramji DP; Labéta MO; Raby AC
    Front Immunol; 2023; 14():1240679. PubMed ID: 37849759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma calprotectin is extremely high in patients with lysinuric protein intolerance.
    Kärki M; Tanner L; Lahtinen S; Soukka T; Niinikoski H
    JIMD Rep; 2023 Jul; 64(4):293-299. PubMed ID: 37404678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary calprotectin, NGAL, and KIM-1 in the differentiation of primarily inflammatory vs. non-inflammatory stable chronic kidney diseases.
    Seibert FS; Sitz M; Passfall J; Haesner M; Laschinski P; Buhl M; Bauer F; Rohn B; Babel N; Westhoff TH
    Ren Fail; 2021 Dec; 43(1):417-424. PubMed ID: 33663323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomarkers in the prediction of contrast media induced nephropathy - the BITCOIN study.
    Seibert FS; Heringhaus A; Pagonas N; Rudolf H; Rohn B; Bauer F; Timmesfeld N; Trappe HJ; Babel N; Westhoff TH
    PLoS One; 2020; 15(7):e0234921. PubMed ID: 32673348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostics, Risk Factors, Treatment and Outcomes of Acute Kidney Injury in a New Paradigm.
    Thongprayoon C; Hansrivijit P; Kovvuru K; Kanduri SR; Torres-Ortiz A; Acharya P; Gonzalez-Suarez ML; Kaewput W; Bathini T; Cheungpasitporn W
    J Clin Med; 2020 Apr; 9(4):. PubMed ID: 32294894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meta-Analysis: Urinary Calprotectin for Discrimination of Intrinsic and Prerenal Acute Kidney Injury.
    Chen JJ; Fan PC; Kou G; Chang SW; Chen YT; Lee CC; Chang CH
    J Clin Med; 2019 Jan; 8(1):. PubMed ID: 30634660
    [No Abstract]   [Full Text] [Related]  

  • 16. Urinary calprotectin and the distinction between prerenal and intrinsic acute kidney injury.
    Heller F; Frischmann S; Grünbaum M; Zidek W; Westhoff TH
    Clin J Am Soc Nephrol; 2011 Oct; 6(10):2347-55. PubMed ID: 21885792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary Calprotectin Differentiates Between Prerenal and Intrinsic Acute Renal Allograft Failure.
    Seibert FS; Rosenberger C; Mathia S; Arndt R; Arns W; Andrea H; Pagonas N; Bauer F; Zidek W; Westhoff TH
    Transplantation; 2017 Feb; 101(2):387-394. PubMed ID: 26901081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Furosemide stress test as a predictive marker of acute kidney injury progression or renal replacement therapy: a systemic review and meta-analysis.
    Chen JJ; Chang CH; Huang YT; Kuo G
    Crit Care; 2020 May; 24(1):202. PubMed ID: 32381019
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.